(Q38033606)

27 August 2017

title

The role of imaging techniques in the management of multiple myeloma (English)

1 reference

27 August 2017

Michele Cavo

2

0 references

author name string

Elena Zamagni

series ordinal

1

1 reference

27 August 2017

language of work or name

English

0 references

publication date

11 August 2012

1 reference

British Journal of Haematology

27 August 2017

published in

1 reference

27 August 2017

volume

159

1 reference

27 August 2017

issue

5

1 reference

27 August 2017

page(s)

499-513

1 reference

99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy

27 August 2017

cites work

1 reference

F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma

21 January 2018

1 reference

Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?

21 January 2018

1 reference

Role of MRI for the diagnosis and prognosis of multiple myeloma

21 January 2018

1 reference

Whole-body MRI versus whole-body MDCT for staging of multiple myeloma.

21 January 2018

1 reference

Value of FDG PET in the assessment of patients with multiple myeloma

21 January 2018

1 reference

The prognostic value of F-18 fluorodeoxyglucose bone marrow uptake in patients with recent diagnosis of multiple myeloma: a comparative study with Tc-99m sestamibi

21 January 2018

1 reference

18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma.

21 January 2018

1 reference

Multiple Myeloma: Molecular Imaging with 11C-Methionine PET/CT--Initial Experience.

21 January 2018

1 reference

Imaging in multiple myeloma

21 January 2018

1 reference

Prediction of progression-free survival in patients with multiple myeloma following anthracycline-based chemotherapy based on dynamic FDG-PET.

21 January 2018

1 reference

International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma

21 January 2018

1 reference

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.

21 January 2018

1 reference

Guidelines for the use of imaging in the management of myeloma.

21 January 2018

1 reference

A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival

21 January 2018

1 reference

Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation

21 January 2018

1 reference

Combining FDG-PET/CT with laboratory data yields superior results for prediction of relapse in multiple myeloma

21 January 2018

1 reference

18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.

21 January 2018

1 reference

Whole-body CT screening: spectrum of findings and recommendations in 1192 patients

21 January 2018

1 reference

Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone

21 January 2018

1 reference

Effect of granulocyte-stimulating factors on marrow of adult patients with musculoskeletal malignancies: incidence and MRI findings.

21 January 2018

1 reference

Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma

21 January 2018

1 reference

Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry

21 January 2018

1 reference

Efficacy of multidetector row computed tomography of the spine in patients with multiple myeloma: comparison with magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography.

21 January 2018

1 reference

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

21 January 2018

1 reference

Magnetic resonance imaging in myeloma.

21 January 2018

1 reference

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

21 January 2018

1 reference

Review of 1027 patients with newly diagnosed multiple myeloma

21 January 2018

1 reference

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

21 January 2018

1 reference

Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging

21 January 2018

1 reference

Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey

21 January 2018

1 reference

Multiple myeloma treatment response assessment with whole-body dynamic contrast-enhanced MR imaging

21 January 2018

1 reference

Role of radiography, MRI and FDG-PET/CT in diagnosing, staging and therapeutical evaluation of patients with multiple myeloma

21 January 2018

1 reference

18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes

21 January 2018

1 reference

A comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma

21 January 2018

1 reference

Comparison of Technetium-99m-MIBI imaging with MRI for detection of spine involvement in patients with multiple myeloma

21 January 2018

1 reference

Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed disease

21 January 2018

1 reference

Multiple myeloma: MR patterns of response to treatment.

21 January 2018

1 reference

Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma

21 January 2018

1 reference

11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma

21 January 2018

1 reference

Predictive value of technetium-99m sestamibi in patients with multiple myeloma and potential role in the follow-up.

21 January 2018

1 reference

FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytoma

21 January 2018

1 reference

Initial results in the assessment of multiple myeloma using 18F-FDG PET.

21 January 2018

1 reference

Positron emission tomography (PET) for staging of solitary plasmacytoma.

21 January 2018

1 reference

Whole-Body MRI versus PET in assessment of multiple myeloma disease activity

21 January 2018

1 reference

The role of whole-body imaging in the diagnosis, staging, and follow-up of multiple myeloma

21 January 2018

1 reference

Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma

21 January 2018

1 reference

Fluorine-18-fluorodeoxyglucose positron emission tomography in response assessment before high-dose chemotherapy for lymphoma: a systematic review and meta-analysis

21 January 2018

1 reference

Myeloma bone disease: pathophysiology and management.

21 January 2018

1 reference

Advances in imaging and the management of myeloma bone disease

21 January 2018

1 reference

¹⁸F-fluoro-deoxyglucose positron emission tomography in assessment of myeloma-related bone disease: a systematic review

21 January 2018

1 reference

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

21 January 2018

1 reference

A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.

21 January 2018

1 reference

Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.

21 January 2018

1 reference

Risk of disease progression in asymptomatic multiple myeloma

21 January 2018

1 reference

Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents

21 January 2018

1 reference

Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI)

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.12007

1 reference

27 August 2017

1 reference